Analysis of signaling pathways in recurrent breast cancer

被引:6
作者
Wu, J. Z. [1 ]
Yang, T. J. [2 ]
Lu, P. [2 ]
Ma, W. [3 ]
机构
[1] Zhengzhou Univ, Breast Canc Diag & Treatment Ctr Henan, Affiliated Canc Hosp, Zhengzhou 450052, Peoples R China
[2] Peoples Hosp Zhengzhou, Gastrointestinal Surg Dept, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China
来源
GENETICS AND MOLECULAR RESEARCH | 2014年 / 13卷 / 04期
关键词
Breast cancer; Pathway; Survival analysis; MOLECULAR PORTRAITS; OXIDATIVE STRESS; EXPRESSION; PATTERNS; DIFFERENTIATION; TRANSCRIPTION; METASTASIS; CARCINOMAS; INITIATION; APOPTOSIS;
D O I
10.4238/2014.December.4.4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Breast cancer remains the second largest cause of death in women from cancer. By analyzing gene expression profiles in samples from breast cancer patients, 844 differentially expressed genes (DEGs) were identified in breast cancer metastasis. The 10 most significant signaling pathways identified through enrichment analysis contained DEGs were involved in oxidative phosphorylation, DNA replication, extracellular matrix-receptor interactions and others. Furthermore, survival analysis demonstrated that 5 of these signaling pathways were closely related to the survival time of breast cancer patients including basal transcription factors, cell cycle, ECM-receptor interaction, spliceosome, and DNA replication. Our findings increase the understanding of the network of signaling pathways involved in breast cancer metastasis and may provide theoretical support for further therapeutic study.
引用
收藏
页码:10097 / 10104
页数:8
相关论文
共 38 条
  • [1] Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts
    An, B
    Goldfarb, RH
    Siman, R
    Dou, QP
    [J]. CELL DEATH AND DIFFERENTIATION, 1998, 5 (12) : 1062 - 1075
  • [2] BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223
  • [3] BERNFIELD M, 1993, DEVELOPMENT, P205
  • [4] Brown NS, 2000, CANCER RES, V60, P6298
  • [5] Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe
    Castedo, M
    Perfettini, JL
    Roumier, T
    Kroemer, G
    [J]. CELL DEATH AND DIFFERENTIATION, 2002, 9 (12) : 1287 - 1293
  • [6] Proteolysis: from the lysosome to ubiquitin and the proteasome
    Ciechanover, A
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (01) : 79 - 86
  • [7] CLAUS EB, 1991, AM J HUM GENET, V48, P232
  • [8] Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells
    Codony-Servat, J
    Tapia, MA
    Bosch, M
    Oliva, C
    Domingo-Domenech, J
    Mellado, B
    Rolfe, M
    Ross, JS
    Gascon, P
    Rovira, A
    Albanell, J
    [J]. MOLECULAR CANCER THERAPEUTICS, 2006, 5 (03) : 665 - 675
  • [9] The proteasome
    Dalton, WS
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (06) : 3 - 9
  • [10] Metalloproteinases: role in breast carcinogenesis, invasion and metastasis
    Duffy, MJ
    Maguire, TM
    Hill, A
    McDermott, E
    O'Higgins, N
    [J]. BREAST CANCER RESEARCH, 2000, 2 (04) : 252 - 257